Literature DB >> 32123306

The novel lncRNA BlackMamba controls the neoplastic phenotype of ALK- anaplastic large cell lymphoma by regulating the DNA helicase HELLS.

Valentina Fragliasso1, Akanksha Verma2,3, Gloria Manzotti1, Annalisa Tameni1,4, Rohan Bareja2, Tayla B Heavican5, Javeed Iqbal5, Rui Wang6, Danilo Fiore6, Valentina Mularoni1, Wing C Chan7, Priscillia Lhoumaud8, Jane Skok8, Eleonora Zanetti9, Francesco Merli10, Alessia Ciarrocchi11, Oliver Elemento12, Giorgio Inghirami13.   

Abstract

The molecular mechanisms leading to the transformation of anaplastic lymphoma kinase negative (ALK-) anaplastic large cell lymphoma (ALCL) have been only in part elucidated. To identify new culprits which promote and drive ALCL, we performed a total transcriptome sequencing and discovered 1208 previously unknown intergenic long noncoding RNAs (lncRNAs), including 18 lncRNAs preferentially expressed in ALCL. We selected an unknown lncRNA, BlackMamba, with an ALK- ALCL preferential expression, for molecular and functional studies. BlackMamba is a chromatin-associated lncRNA regulated by STAT3 via a canonical transcriptional signaling pathway. Knockdown experiments demonstrated that BlackMamba contributes to the pathogenesis of ALCL regulating cell growth and cell morphology. Mechanistically, BlackMamba interacts with the DNA helicase HELLS controlling its recruitment to the promoter regions of cell-architecture-related genes, fostering their expression. Collectively, these findings provide evidence of a previously unknown tumorigenic role of STAT3 via a lncRNA-DNA helicase axis and reveal an undiscovered role for lncRNA in the maintenance of the neoplastic phenotype of ALK-ALCL.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32123306     DOI: 10.1038/s41375-020-0754-8

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  51 in total

1.  Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma.

Authors:  Ramona Crescenzo; Francesco Abate; Elena Lasorsa; Fabrizio Tabbo'; Marcello Gaudiano; Nicoletta Chiesa; Filomena Di Giacomo; Elisa Spaccarotella; Luigi Barbarossa; Elisabetta Ercole; Maria Todaro; Michela Boi; Andrea Acquaviva; Elisa Ficarra; Domenico Novero; Andrea Rinaldi; Thomas Tousseyn; Andreas Rosenwald; Lukas Kenner; Lorenzo Cerroni; Alexander Tzankov; Maurilio Ponzoni; Marco Paulli; Dennis Weisenburger; Wing C Chan; Javeed Iqbal; Miguel A Piris; Alberto Zamo'; Carmela Ciardullo; Davide Rossi; Gianluca Gaidano; Stefano Pileri; Enrico Tiacci; Brunangelo Falini; Leonard D Shultz; Laurence Mevellec; Jorge E Vialard; Roberto Piva; Francesco Bertoni; Raul Rabadan; Giorgio Inghirami
Journal:  Cancer Cell       Date:  2015-04-13       Impact factor: 31.743

2.  Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma.

Authors:  Luca Agnelli; Elisabetta Mereu; Elisa Pellegrino; Tania Limongi; Ivo Kwee; Elisa Bergaggio; Maurilio Ponzoni; Alberto Zamò; Javeed Iqbal; Pier Paolo Piccaluga; Antonino Neri; Wing C Chan; Stefano Pileri; Francesco Bertoni; Giorgio Inghirami; Roberto Piva
Journal:  Blood       Date:  2012-06-27       Impact factor: 22.113

3.  Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma.

Authors:  Javeed Iqbal; George Wright; Chao Wang; Andreas Rosenwald; Randy D Gascoyne; Dennis D Weisenburger; Timothy C Greiner; Lynette Smith; Shuangping Guo; Ryan A Wilcox; Bin Tean Teh; Soon Thye Lim; Soon Yong Tan; Lisa M Rimsza; Elaine S Jaffe; Elias Campo; Antonio Martinez; Jan Delabie; Rita M Braziel; James R Cook; Raymond R Tubbs; German Ott; Eva Geissinger; Philippe Gaulard; Pier Paolo Piccaluga; Stefano A Pileri; Wing Y Au; Shigeo Nakamura; Masao Seto; Francoise Berger; Laurence de Leval; Joseph M Connors; James Armitage; Julie Vose; Wing C Chan; Louis M Staudt
Journal:  Blood       Date:  2014-03-14       Impact factor: 22.113

4.  Identification of a new subclass of ALK-negative ALCL expressing aberrant levels of ERBB4 transcripts.

Authors:  Irene Scarfò; Elisa Pellegrino; Elisabetta Mereu; Ivo Kwee; Luca Agnelli; Elisa Bergaggio; Giulia Garaffo; Nicoletta Vitale; Manuel Caputo; Rodolfo Machiorlatti; Paola Circosta; Francesco Abate; Antonella Barreca; Domenico Novero; Susan Mathew; Andrea Rinaldi; Enrico Tiacci; Sara Serra; Silvia Deaglio; Antonino Neri; Brunangelo Falini; Raul Rabadan; Francesco Bertoni; Giorgio Inghirami; Roberto Piva
Journal:  Blood       Date:  2015-10-13       Impact factor: 22.113

5.  PRDM1/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma.

Authors:  Michela Boi; Andrea Rinaldi; Ivo Kwee; Paola Bonetti; Maria Todaro; Fabrizio Tabbò; Roberto Piva; Paola M V Rancoita; András Matolcsy; Botond Timar; Thomas Tousseyn; Socorro Maria Rodríguez-Pinilla; Miguel A Piris; Sílvia Beà; Elias Campo; Govind Bhagat; Steven H Swerdlow; Andreas Rosenwald; Maurilio Ponzoni; Ken H Young; Pier Paolo Piccaluga; Reinhard Dummer; Stefano Pileri; Emanuele Zucca; Giorgio Inghirami; Francesco Bertoni
Journal:  Blood       Date:  2013-09-04       Impact factor: 22.113

Review 6.  The 2016 revision of the World Health Organization classification of lymphoid neoplasms.

Authors:  Steven H Swerdlow; Elias Campo; Stefano A Pileri; Nancy Lee Harris; Harald Stein; Reiner Siebert; Ranjana Advani; Michele Ghielmini; Gilles A Salles; Andrew D Zelenetz; Elaine S Jaffe
Journal:  Blood       Date:  2016-03-15       Impact factor: 22.113

Review 7.  The biology and management of systemic anaplastic large cell lymphoma.

Authors:  Greg Hapgood; Kerry J Savage
Journal:  Blood       Date:  2015-04-13       Impact factor: 22.113

Review 8.  Anaplastic large cell lymphoma, ALK-negative.

Authors:  Andrés J M Ferreri; Silvia Govi; Stefano A Pileri; Kerry J Savage
Journal:  Crit Rev Oncol Hematol       Date:  2012-07-11       Impact factor: 6.312

9.  Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target.

Authors:  Roberto Chiarle; William J Simmons; Honjying Cai; Girish Dhall; Alberto Zamo; Regina Raz; James G Karras; David E Levy; Giorgio Inghirami
Journal:  Nat Med       Date:  2005-05-15       Impact factor: 53.440

10.  ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes.

Authors:  Edgardo R Parrilla Castellar; Elaine S Jaffe; Jonathan W Said; Steven H Swerdlow; Rhett P Ketterling; Ryan A Knudson; Jagmohan S Sidhu; Eric D Hsi; Shridevi Karikehalli; Liuyan Jiang; George Vasmatzis; Sarah E Gibson; Sarah Ondrejka; Alina Nicolae; Karen L Grogg; Cristine Allmer; Kay M Ristow; Wyndham H Wilson; William R Macon; Mark E Law; James R Cerhan; Thomas M Habermann; Stephen M Ansell; Ahmet Dogan; Matthew J Maurer; Andrew L Feldman
Journal:  Blood       Date:  2014-06-03       Impact factor: 22.113

View more
  5 in total

Review 1.  Long non-coding RNAs: the tentacles of chromatin remodeler complexes.

Authors:  Audrey Vincent; Isabelle Van Seuningen; Bernadette Neve; Nicolas Jonckheere
Journal:  Cell Mol Life Sci       Date:  2020-10-01       Impact factor: 9.261

2.  A 9-LncRNA Signature for Predicting Prognosis and Immune Response in Diffuse Large B-Cell Lymphoma.

Authors:  Xiaoxuan Wang; Yaxiao Lu; Ziyi Liu; Yidan Zhang; You He; Cong Sun; Lanfang Li; Qiongli Zhai; Bin Meng; Xiubao Ren; Xudong Wu; Huilai Zhang; Xianhuo Wang
Journal:  Front Immunol       Date:  2022-07-06       Impact factor: 8.786

3.  A Novel JAK1 Mutant Breast Implant-Associated Anaplastic Large Cell Lymphoma Patient-Derived Xenograft Fostering Pre-Clinical Discoveries.

Authors:  Danilo Fiore; Luca Vincenzo Cappelli; Paul Zumbo; Jude M Phillips; Zhaoqi Liu; Shuhua Cheng; Liron Yoffe; Paola Ghione; Federica Di Maggio; Ahmet Dogan; Inna Khodos; Elisa de Stanchina; Joseph Casano; Clarisse Kayembe; Wayne Tam; Doron Betel; Robin Foa'; Leandro Cerchietti; Raul Rabadan; Steven Horwitz; David M Weinstock; Giorgio Inghirami
Journal:  Cancers (Basel)       Date:  2020-06-17       Impact factor: 6.639

4.  The DNA-helicase HELLS drives ALK- ALCL proliferation by the transcriptional control of a cytokinesis-related program.

Authors:  Valentina Fragliasso; Alessia Ciarrocchi; Annalisa Tameni; Elisabetta Sauta; Valentina Mularoni; Federica Torricelli; Gloria Manzotti; Giorgio Inghirami; Riccardo Bellazzi
Journal:  Cell Death Dis       Date:  2021-01-27       Impact factor: 8.469

Review 5.  Cytoskeleton Dynamics in Peripheral T Cell Lymphomas: An Intricate Network Sustaining Lymphomagenesis.

Authors:  Valentina Fragliasso; Annalisa Tameni; Giorgio Inghirami; Valentina Mularoni; Alessia Ciarrocchi
Journal:  Front Oncol       Date:  2021-04-13       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.